US EditionPublished • loading... • Updated
Castle Biosciences, Inc. (CSTL) Stock Analysis: A 47.15% Potential Upside In Healthcare Diagnostics
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Castle Biosciences, Inc. (CSTL) Stock Analysis: A 47.15% Potential Upside In Healthcare Diagnostics
Castle Biosciences, Inc. (NASDAQ: CSTL) stands out in the healthcare diagnostics sector with its innovative molecular diagnostics solutions. Headquartered in Friendswood, Texas, Castle Biosciences provides test solutions primarily for dermatologic cancers and mental health conditions. With a market capitalization of $702.29 million, the company is making waves with promising growth potential and a notable upside. Castle Biosciences specializes i…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
